+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06114628

Evaluating Multiple Drug Regimens and Treatment Durations for Pulmonary Tuberculosis in a Global Phase 2BC Platform Trial

Led by University College, London · Updated on 2026-10-15

2500

Participants Needed

11

Research Sites

24 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating new treatment regimens for pulmonary tuberculosis TB that aim to be faster while maintaining safety and effectiveness. This trial is conducted by the UNITE4TB consortium, a collaboration of universities and pharmaceutical companies, funded by the European Union. The study focuses on adults with newly diagnosed rifampicin-susceptible pulmonary TB and includes both drug-susceptible and potentially drug-resistant cases to find improved therapies. The trial has two main parts. In Phase 2B, up to 700 participants will be randomly assigned to one of several treatment groups, including a standard 24-week regimen and up to 16-week novel regimens combining new drugs like BTZ-043 and GSK3036656 with existing TB medications. Phase 2C will involve up to 1800 participants receiving selected regimens from Phase 2B for varying durations between 8 and 16 weeks. The study drugs are given orally with specific doses, and treatment combinations may change during the trial. Participants will be followed for a total of 72 weeks to monitor treatment response and safety. Assessments include measuring the time to positivity of sputum cultures, adverse events, and treatment outcomes such as relapse or failure. Safety monitoring covers serious and special interest adverse events. The trial includes regular visits and laboratory tests to evaluate the effectiveness and tolerability of the treatments over the duration of the study.

CONDITIONS

Brief Title

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Research Team

S

Susie Slater

K

Karen Sanders

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here